High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study

ABSTRACTBackground: Cyclosporine A (CsA) and regular doses of recombinant human thrombopoietin (rhTPO) can accelerate platelet recovery in patients with non-severe aplastic anemia (NSAA). However, it is unclear whether CsA plus rhTPO at a higher dose can further increase the efficacy.Methods: Data f...

Full description

Bibliographic Details
Main Authors: Yuan Yang, Qinglin Hu, Chen Yang, Miao Chen, Bing Han
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
Non-severe aplastic anemia
recombinant human thrombopoietin
cyclosporine A
response
platelet recovery
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2023.2298523

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2023.2298523

Similar Items